Search results
Added:
2 months ago
ACC.26 – Dr Navin Kapur (Tufts Medicine, Boston, MA, US) joins us to discuss findings from the STEMI-Door To Unload (DTU) randomised clinical trial, examining whether primary left ventricular unloading with the Impella CP® device prior to reperfusion can reduce infarct size and heart failure-related outcomes in patients presenting with anterior ST-elevation myocardial infarction.This prospective,…
View more
Added:
1 year ago
ESC Congress 2024 — Complete revascularisation is safe, reduces ischemic events for up to 4 years, and does not affect long-term mortality.We are joined onsite by Dr Gianluca Campo (University of Ferrara, Ferrara, IT) to discuss the findings from EARTH-STEMI. Previous RCTs have supported the benefit of complete revascularisation in the overall population, however, this has not been confirmed in…
View more
Added:
2 months ago
ACC.26 - In the first episode of Between the Sessions, Dr Purvi Parwani breaks down the biggest stories and early clinical insights from day 1 of the American College of Cardiology 2026 (ACC 2026) meeting.In this quick five‑minute recap, she highlights the trials sparking the most discussion among cardiologists – including CHAMPION‑AF, HI‑PEITHO and STEMI‑DTU – focusing on studies with the…
View more
Complete Revascularisation in STEMI: Do We Really Buy It?
Added:
1 month ago
Review Article
Added:
2 months ago
Added:
2 months ago
Source:
Cardiac Failure Review
The optimal timing for complete revascularisation in patients with ST-segment elevation myocardial infarction (STEMI) and multi-vessel disease who also present with heart failure is a key clinical question. A pre-specified subgroup analysis of the OPTION-STEMI trial suggests that a staged approach may be preferable to immediate complete revascularisation in this high-risk patient group…
View more
Added:
1 year ago
EuroPCR 25 - 10-year outcomes from DANAMI-3-PRIMULTI show FFR-guided complete revascularisation in ST-elevation myocardial infarction (STEMI) reduces the risk of future events. We are joined by Dr Thomas Engstrøm (University of Copenhagen, Copenhagen, Denmark) to discuss 10-year outcomes from the multicenter, randomized DANAMI-3-PRIMULTI trial investigating FFR-guided complete…
View more
Added:
1 year ago
EuroPCR 25 - 10-year follow-up findings of DANAMI-3-DEFER show a deferred stenting strategy may reduce HF hospitalisation in ST-elevation myocardial infarction (STEMI) patients.We are joined by Dr Jacob Lønborg (Rigshospitalet, Copenhagen, DK) to discuss key findings from the 10-year follow-up of the DANAMI-3-DEFER (NCT01435408) trial. This randomized controlled trial compared deferred stent…
View more
OPTION–STEMI: Immediate Complete Revascularisation Fails to Show Non-Inferiority to Staged Approach
Added:
9 months ago
Source:
Transcatheter Academy
News
Added:
7 months ago
Source:
Radcliffe Cardiology
The optimal timing for treating nonculprit lesions in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease remains a key clinical question. The iMODERN trial investigated whether an immediate intervention strategy was superior to a deferred approach in this patient population.¹The international, investigator-initiated, open-label iMODERN (Immediate or Deferred…
View more